Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation and Depletion (2017 - 2025)

Historic Depreciation and Depletion for Rockwell Medical (RMTI) over the last 9 years, with Q3 2025 value amounting to $400000.0.

  • Rockwell Medical's Depreciation and Depletion changed 0.0% to $400000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.6 million for FY2024, which is 3333.33% up from last year.
  • Latest data reveals that Rockwell Medical reported Depreciation and Depletion of $400000.0 as of Q3 2025, which was down 0.0% from $400000.0 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Depreciation and Depletion registered a high of $400000.0 during Q3 2023, and its lowest value of $100000.0 during Q3 2021.
  • Its 5-year average for Depreciation and Depletion is $272000.0, with a median of $200000.0 in 2021.
  • As far as peak fluctuations go, Rockwell Medical's Depreciation and Depletion plummeted by 5000.0% in 2021, and later surged by 30000.0% in 2023.
  • Over the past 5 years, Rockwell Medical's Depreciation and Depletion (Quarter) stood at $168000.0 in 2021, then rose by 19.05% to $200000.0 in 2022, then surged by 100.0% to $400000.0 in 2023, then changed by 0.0% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025.
  • Its last three reported values are $400000.0 in Q3 2025, $400000.0 for Q2 2025, and $400000.0 during Q1 2025.